Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

876
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
876
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

932
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
932
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

435
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
435
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

429
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
429
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

735
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
735
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

1.9K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Intraprocedural Fibrin Clot Formation During Pulmonary Vein Isolation With a Lattice-Tip Ablation Catheter.

Journal of cardiovascular electrophysiology·2026
Same author

Silent Thyroid, Loud Lipids: The Hidden Link in Asymptomatic Adults.

Juntendo medical journal·2026
Same author

Safety Profile of Warfarin and Apixaban for Deep Vein Thrombosis in Patients With Chronic Kidney Disease.

Cureus·2026
Same author

Co-amplification of microbial DNA: A novel observation of a misconstrued second peak at locus D7S820.

Forensic science international·2024
Same author

Lumbar Erector Spinae Plane Block for Total Hip Arthroplasty Comparing 24-Hour Opioid Requirements: A Randomized Controlled Study.

Anesthesiology research and practice·2022
Same author

PFSA DNA database: A tool to hunt the serial offenders.

Forensic science international·2021

相关实验视频

Updated: Jan 10, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.6K

一个患有性结肠炎的患者的复发性困难结肠杆菌感染:一个病例报告

Osama Nadeem1, Muhammad Soban Imran2, Nasir Siddique1

  • 1General Medicine, North Manchester General Hospital, Manchester, GBR.

Cureus
|November 24, 2025
PubMed
概括

复发性困难菌感染 (CDI) 是老年性结肠炎 (UC) 患者的一个严重挑战. 这种病例显示,尽管进行了各种治疗,但CDI发作多次,导致致命的败血症休克,强调了需要替代疗法的必要性.

科学领域:

  • 胃肠病学 胃肠病学
  • 传染性疾病 传染性疾病
  • 临床案例研究临床案例研究

背景情况:

  • 困难菌感染 (CDI) 提出了重大挑战,特别是在炎症性肠病 (IBD) 患者,如性结肠炎 (UC) 患者.
  • 与普通人群相比,UC患者面临CDI的风险较高,患病率更严重,复发率更高.

研究的目的:

  • 为了在老年患者中呈现一种复发性CDI病例,该患者有UC病史.
  • 要突出复杂性和增加的发病率在管理复发性CDI在这个特定的人口.

主要方法:

  • 一份病例报告详细介绍了一名老年男性患者长期患有UC和CDI病史.
  • 在四个月的住院期间,通过便PCR和毒素测定确认了三个单独的CDI发作.
  • 连续使用万科米辛,甲尼达和菲达克索米辛进行治疗.

主要成果:

  • 患者经历了CDI的三次复发发作,尽管连续接受了抗生素治疗.
  • 重复的CDI最终导致了败血症休克和死亡.
  • 这一案例说明了老年UC患者治疗复发性CDI的困难性.

结论:

  • 老年UC患者的复发性CDI是复杂的,并与高发病率相关.
关键词:
与抗生素相关的腹.困难菌感染 治疗 治疗 困难菌感染年长的病人,老年患者.炎症性肠病是一种炎症性肠病.梅萨拉辛 (Mesalazine) 是一种可怕的药物.经常发生的CDI.性肠炎的原因是什么

更多相关视频

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.1K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.3K

相关实验视频

Last Updated: Jan 10, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.6K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.1K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.3K
  • 强调评估风险因素和明智使用抗生素的重要性.
  • 建议考虑替代治疗方法,如便微生物群移植 (FMT),以预防复发性CDI.